Abstract
Background—
Thoracic endovascular aortic repair (TEVAR) represents a therapeutic concept for type B aortic dissection. Long-term outcomes and morphology after TEVAR for uncomplicated dissection are unknown.


Methods and Results—

A total of 140 patients with stable type B aortic dissection previously randomized to optimal medical treatment and TEVAR (n=72) versus optimal medical treatment alone (n=68) were analyzed retrospectively for aorta-specific, all-cause outcomes, and disease progression using landmark statistical analysis of years 2 to 5 after index procedure. Cox regression was used to compare outcomes between groups; all analyses are based on intention to treat. The risk of all-cause mortality (11.1% versus 19.3%;
P
=0.13), aorta-specific mortality (6.9% versus 19.3%;
P
=0.04), and progression (27.0% versus 46.1%;
P
=0.04) after 5 years was lower with TEVAR than with optimal medical treatment alone. Landmark analysis suggested a benefit of TEVAR for all end points between 2 and 5 years; for example, for all-cause mortality (0% versus 16.9%;
P
=0.0003), aorta-specific mortality (0% versus 16.9%;
P
=0.0005), and for progression (4.1% versus 28.1%;
P
=0.004); Landmarking at 1 year and 1 month revealed consistent findings. Both improved survival and less progression of disease at 5 years after elective TEVAR were associated with stent graft induced false lumen thrombosis in 90.6% of cases (
P
<0.0001).



Conclusions—
In this study of survivors of type B aortic dissection, TEVAR in addition to optimal medical treatment is associated with improved 5-year aorta-specific survival and delayed disease progression. In stable type B dissection with suitable anatomy, preemptive TEVAR should be considered to improve late outcome.


Clinical Trial Registration—

URL:
http://www.clinicaltrials.gov
. Unique identifier: NCT01415804.
Topics

No keywords indexed for this article. Browse by subject →

References
41
[1]
Endovascular Stent–Graft Placement for the Treatment of Acute Aortic Dissection

Michael D. Dake, Noriyuki Kato, R. SCOTT MITCHELL et al.

New England Journal of Medicine 10.1056/nejm199905203402004
[22]
Long-Term Survival in Patients Presenting With Type B Acute Aortic Dissection

Thomas T. Tsai, Rossella Fattori, Santi Trimarchi et al.

Circulation 10.1161/circulationaha.106.622340
[27]
Takahashi J, Wakamatsu Y, Okude J, Kanaoka T, Sanefuji Y, Gohda T, Sasaki S, Matsui Y. Maximum aortic diameter as a simple predictor of acute type B aortic dissection. Ann Thorac Cardiovasc Surg. 2008;14:303–310.
[31]
Trimarchi S, Nienaber CA, Rampoldi V, Myrmel T, Suzuki T, Bossone E, Tolva V, Deeb MG, Upchurch GR, Cooper JV, Fang J, Isselbacher EM, Sundt TM, Eagle KA; IRAD Investigators. Role and results of surgery in acute type B aortic dissection: insights from the International Registry of Acute Aortic Dissection (IRAD). Circulation. 2006;114(1 suppl):I357–I364.
Cited By
944
Seminars in Vascular Surgery
Annals of Vascular Surgery
The Journal of Thoracic and Cardiov...
IEEE Journal of Biomedical and Heal...
European Heart Journal
Intervenční a akutní kardiologie
Aortic dissection

Christoph A. Nienaber, Rachel E. Clough · 2016

Nature Reviews Disease Primers
Metrics
944
Citations
41
References
Details
Published
Aug 01, 2013
Vol/Issue
6(4)
Pages
407-416
Authors
Cite This Article
Christoph A. Nienaber, Stephan Kische, Hervé Rousseau, et al. (2013). Endovascular Repair of Type B Aortic Dissection. Circulation: Cardiovascular Interventions, 6(4), 407-416. https://doi.org/10.1161/circinterventions.113.000463